| Genomic epidemiology and phylodynamics for county-to-county transmission of SARS-CoV-2 in Minnesota, from 19A to Omicron | | |
| Recent insights into COVID-19 in children and clinical recommendations | Current Pediatric Reviews | 2021 |
| COVID-19 Therapeutics: Making Sense of It All | AACN Advanced Critical Care | 2020 |
| Study of Epidemiological Characteristics and In-silico Analysis of the Effect of Interventions in the SARS-CoV-2 Epidemic in India | | |
| COVID-19 ‘The Pandemic’: An Update on the Present Status of the Outbreak and Possible Treatment Options | Biomedical and Pharmacology Journal | 2020 |
| Treatment of COVID-19 Patients with Convalescent Plasma in Houston, Texas | | 2020 |
| Peripheral oxygen saturation to inspiratory oxygen fraction ratio-based identification of critically ill coronavirus disease patients for early therapeutic interventions | Journal of Anesthesia | 2021 |
| Common anti-COVID-19 drugs and their anticipated interaction with anesthetic agents | Journal of Anaesthesiology Clinical Pharmacology | 2021 |
| Immunity, endothelial injury and complement-induced coagulopathy in COVID-19 | Nature Reviews Nephrology | 2021 |
| Tackling COVID-19 Using Remdesivir and Favipiravir as Therapeutic Options | ChemBioChem | 2021 |
| The race against COVID-19 | Nature Nanotechnology | 2020 |
| Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19 | The Cochrane Library | 2020 |
| Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019 | Pharmacotherapy | 2020 |
| Roles of the clinical pharmacist during the COVID-19 pandemic | JACCP Journal of the American College of Clinical Pharmacy | 2020 |
| COVID-19 and Older Adults: What We Know | Journal of the American Geriatrics Society | 2020 |
| Rapid Identification of Potential Inhibitors of SARS-CoV-2 Main Protease by Deep Docking of 1.3 Billion Compounds | Molecular Informatics | 2020 |
| Available Evidence and Ongoing Clinical Trials of Remdesivir: Could It Be a Promising Therapeutic Option for COVID-19? | Frontiers in Pharmacology | 2020 |
| Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical trials and recent advancements | Life Sciences | 2020 |
| Drug repurposing against COVID-19: focus on anticancer agents | Journal of Experimental and Clinical Cancer Research | 2020 |
| Inclusion of Children in Clinical Trials of Treatments for Coronavirus Disease 2019 (COVID-19) | JAMA Pediatrics | 2020 |
| Obstacles and Considerations Related to Clinical Trial Research During the COVID-19 Pandemic | Frontiers in Medicine | 2020 |
| Pharmacological treatments of COVID-19 | Pharmacological Reports | 2020 |
| Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives | Frontiers in Pharmacology | 2020 |
| COVID-19 pandemic and the tension between the need to act and the need to know | Internal Medicine Journal | 2020 |
| A multi-centre open-label two-arm randomised superiority clinical trial of azithromycin versus usual care in ambulatory COVID-19: study protocol for the ATOMIC2 trial | Trials | 2020 |
| COVID-19 has no effect on gravity | BMJ Surgery, Interventions, and Health Technologies | 2020 |
| Role of comorbidities like diabetes on severe acute respiratory syndrome coronavirus-2: A review | Life Sciences | 2020 |
| The Impact of Pre-existing Comorbidities and Therapeutic Interventions on COVID-19 | Frontiers in Immunology | 2020 |
| A Review on Remdesivir: A Possible Promising Agent for the Treatment of COVID-19 | Drug Design, Development and Therapy | 2020 |
